Delivra Health Brands Adds Veteran CPG Executive John Barrett to Board

Delivra Health Brands ( (TSE:DHB) ) has shared an update.

Delivra Health Brands has appointed John Barrett, a veteran consumer goods executive with senior leadership experience at Frito Lay, PepsiCo and Pernod Ricard, to its board of directors, replacing outgoing director Andrew Bayfield. Currently head of boutique consultancy Kites Advisors, Barrett brings extensive North American and international expertise in innovation, marketing, commercial strategy, major customer acquisition and profit-and-loss management, which the company’s executive chair says will be key as Delivra pursues its next phase of growth and seeks to strengthen execution of its strategic priorities and long-term value creation, subject to TSX Venture Exchange approval.

The most recent analyst rating on (TSE:DHB) stock is a Hold with a C$0.21 price target. To see the full list of analyst forecasts on Delivra Health Brands stock, see the TSE:DHB Stock Forecast page.

Spark’s Take on TSE:DHB Stock

According to Spark, TipRanks’ AI Analyst, TSE:DHB is a Neutral.

The score is primarily weighed down by weak financial quality—ongoing losses and negative operating/free cash flow despite strong revenue growth and solid gross margins. Technicals are also bearish with the stock trading below major moving averages and a negative MACD, while valuation signals are limited due to a negative P/E and no dividend support.

To see Spark’s full report on TSE:DHB stock, click here.

More about Delivra Health Brands

Delivra Health Brands Inc. is a Vancouver-based consumer packaged goods company operating in the health and wellness sector. Its portfolio includes innovative alternative wellness brands such as Dream Water and LivRelief, which target common everyday issues like chronic pain, anxiety and sleeplessness, aiming to help consumers improve mobility, energy and overall quality of life.

Average Trading Volume: 21,331

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$6.1M

See more data about DHB stock on TipRanks’ Stock Analysis page.